Director
DIN: 05203200
Jigar Prahladbhai Agrawal is currently associated with 3 companies in various capacities such as Partner, Designated Partner and Director. They serve as a Director at OKVIN PHARMACEUTICALS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05203200.Jigar Prahladbhai Agrawal has previously been associated with 1 company in roles such as Director.Jigar Prahladbhai Agrawal is currently involved in 3 different roles. Their most recent position is with HETWIK F & B PRIVATE LIMITED as a Director. The first company Jigar Prahladbhai Agrawal was appointed to as a director was OKVIN PHARMACEUTICALS LLP. Jigar Prahladbhai Agrawal is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Jigar Prahladbhai Agrawal is currently associated with 3 companies in various capacities such as Partner, Designated Partner and Director. They serve as a Director at OKVIN PHARMACEUTICALS LLP and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05203200.Jigar Prahladbhai Agrawal has previously been associated with 1 company in roles such as Director.Jigar Prahladbhai Agrawal is currently involved in 3 different roles. Their most recent position is with HETWIK F & B PRIVATE LIMITED as a Director. The first company Jigar Prahladbhai Agrawal was appointed to as a director was OKVIN PHARMACEUTICALS LLP. Jigar Prahladbhai Agrawal is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (1)
Current LLPs (2)
Past Companies (1)
2y 11m 1y 6m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| HETWIK F & B PRIVATE LIMITED | Director | 19-Jan-2026 |